Breaking News Instant updates and real-time market news.

CVS

CVS Health

$73.20

-0.32 (-0.44%)

, AET

Aetna

$181.80

1.11 (0.61%)

07:03
01/04/18
01/04
07:03
01/04/18
07:03

CVS Health now sees Q4 adjusted EPS at lower end of $1.88-$1.92 range

Consensus $1.90. As previously announced, CVS (CVS) suspended share repurchases during the fourth quarter of 2017 due to its pending acquisition of Aetna (AET). Absent the suspension, share repurchases in 2018 would have contributed approximately 340 to 610 basis points of growth to adjusted EPS. The company had also previously announced that it would maintain its current annual dividend of $2.00 per share throughout the year. Additionally, the company revised its outlook for the fourth quarter of 2017. Due to softer margin performance in the PBM's client and retail network claims management process, the company now expects a mid-teens growth rate in the fourth quarter and about 4% for the full year for the Pharmacy Services segment's adjusted operating profit. The company continues to expect fourth quarter operating profit from its Retail/LTC segment to be at the high end of its previously-provided range of (3.5%) to (1.0%). Combined with the impact from the suspension of share repurchases, offset by a better effective tax rate, the company expects to deliver adjusted consolidated operating profit growth and adjusted EPS at the lower end of their respective ranges provided during its third quarter 2017 earnings call. At that time, the company expected adjusted consolidated operating profit growth of 5.75% to 8% and adjusted EPS of $1.88 to $1.92. Also, the company expects to meaningfully benefit in the fourth quarter from the Tax Cuts and Jobs Act, but estimates of these benefits have not been included as the company is currently assessing the law's impact on its 2017 financial statements.

CVS

CVS Health

$73.20

-0.32 (-0.44%)

AET

Aetna

$181.80

1.11 (0.61%)

  • 04

    Jan

  • 04

    Jan

CVS CVS Health
$73.20

-0.32 (-0.44%)

12/20/17
MSCO
12/20/17
DOWNGRADE
Target $207
MSCO
Equal Weight
Aetna downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Zack Sopcak downgraded Aetna (AET) to Equal Weight from Overweight and increased his price target on the stock to $207 from $192, stating that he see it as unlikely that the company will get other bids to challenge CVS Health (CVS).
01/02/18
NEED
01/02/18
NO CHANGE
Target $88
NEED
Buy
CVS Health will have multiple 2018 catalysts, says Needham
Needham analyst Kevin Caliendo raised his price target on CVS Health (CVS) to $88 from $85 while keeping his Buy rating. Caliendo says he has been frustrated on the lack of movement in the stock following the Aetna (AET) merger announcement, attributing "investor apathy" to confusion over the management's guidance and lack of clarity around the tax reform impact. The analyst estimates that the company's corporate tax rate will move to about 26% from 39% and also models about $1 in net positive EPS accretion from the Aetna deal in 2019. Caliendo lists the company's S-4 filing in early January and the road show promoting the merger as key catalysts in the near term.
01/03/18
PIPR
01/03/18
UPGRADE
Target $207
PIPR
Overweight
Aetna upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James upgraded Aetna (AET) to Overweight and raised her price target for the shares to $207 from $187. The analyst sees a potential "win-win" scenario surrounding the outcome of the CVS Health (CVS) buyout. If the deal goes through James sees 15% share upside. If the deal does not go through, Aetna is set up for "strong operational performance" with stock appreciation potential of 15% by year end, the analyst contends.
01/04/18
RAJA
01/04/18
UPGRADE
RAJA
Strong Buy
CVS Health upgraded to Strong Buy from Outperform at Raymond James
AET Aetna
$181.80

1.11 (0.61%)

12/28/17
LEER
12/28/17
NO CHANGE
LEER
CMS Medicare Advantage Payment Notice positive for Humana, UnitedHealth, says Leerink
Leerink analyst Ana Gupte views the CMS 2019 Medicare Advantage Payment Notice with Methodological Changes on Risk Adjusters as a likely positive precursor to the actual rate change and a positive catalyst. The analyst believes the notice is most positive for Humana (HUM), UnitedHealth (UNH) and WellCare (WCG), but also positive for the sector as a whole including Aetna (AET), Cigna (CI), Anthem (ANTM), Centene (CNC) and Molina Healthcare (MOH). The notice offers a change in the risk adjustment methodology that is more industry friendly than the status quo and this combined with a 4% underlying cost trend expectation should offer a positive advance rate announcement in February and final in April. Gupte also expects that the Republican Administration will drive tax reform as part of an imperative to reaccelerate what is likely irreversible privatization of Medicare, after the slowdown as part of the budget cuts in the era of ObamaCare.

TODAY'S FREE FLY STORIES

VNOM

Viper Energy

$38.34

0.91 (2.43%)

21:49
08/16/18
08/16
21:49
08/16/18
21:49
Upgrade
Viper Energy rating change  »

Viper Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIFE

aTyr Pharma

$0.63

(0.00%)

21:45
08/16/18
08/16
21:45
08/16/18
21:45
Upgrade
aTyr Pharma rating change  »

aTyr Pharma upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$77.25

1.04 (1.36%)

21:44
08/16/18
08/16
21:44
08/16/18
21:44
Downgrade
Hilton rating change  »

Hilton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$335.46

-3.2 (-0.94%)

20:50
08/16/18
08/16
20:50
08/16/18
20:50
Periodicals
Tesla Fremont facility workers left 3.5 hours early on Wednesday, BI reports »

Workers at Tesla's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

20:43
08/16/18
08/16
20:43
08/16/18
20:43
Periodicals
Pentagon: China expanded bomber training to overwater areas, Reuters says »

In its annual report, the…

SPX

S&P 500

$0.00

(0.00%)

FXI

iShares China Large-Cap ETF

$41.00

0.41 (1.01%)

BA

Boeing

$345.89

14.16 (4.27%)

HII

Huntington Ingalls

$244.50

3.68 (1.53%)

LMT

Lockheed Martin

$325.86

8.31 (2.62%)

NOC

Northrop Grumman

$291.97

0.45 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$137.38

1.68 (1.24%)

20:25
08/16/18
08/16
20:25
08/16/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

MCD

McDonald's

$161.71

1.82 (1.14%)

19:48
08/16/18
08/16
19:48
08/16/18
19:48
Hot Stocks
FDA updates on investigation of McDonald's salad-related Cyclospora illnesses »

As of August 16, 2018, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

TRP

TransCanada

$43.82

0.05 (0.11%)

19:40
08/16/18
08/16
19:40
08/16/18
19:40
Hot Stocks
TransCanada does not endorse mini-tender by TRC Capital »

TransCanada has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$30.70

1.4 (4.78%)

, INSE

Inspired Entertainment

$7.15

(0.00%)

19:21
08/16/18
08/16
19:21
08/16/18
19:21
Hot Stocks
Scientific Games and Pennsylvania Lottery launch virtual sports »

Scientific Games (SGMS)…

SGMS

Scientific Games

$30.70

1.4 (4.78%)

INSE

Inspired Entertainment

$7.15

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$15.63

0.23 (1.49%)

19:19
08/16/18
08/16
19:19
08/16/18
19:19
Syndicate
Krystal Biotech announces $10M private placement with Frazier Healthcare »

Krystal Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LBC

Luther Burbank

$10.90

-0.09 (-0.82%)

19:08
08/16/18
08/16
19:08
08/16/18
19:08
Hot Stocks
Luther Burbank authorizes stock buyback of up to $15M »

Luther Burbank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ARAY

Accuray

$3.50

0.05 (1.45%)

, JWN

Nordstrom

$52.30

0.44 (0.85%)

19:00
08/16/18
08/16
19:00
08/16/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

ARAY

Accuray

$3.50

0.05 (1.45%)

JWN

Nordstrom

$52.30

0.44 (0.85%)

CRMT

America's Car-Mart

$66.95

1.85 (2.84%)

ATAI

ATA Inc.

$6.87

0.13 (1.93%)

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

VJET

voxeljet

$3.51

0.11 (3.24%)

VNET

21Vianet

$9.45

0.44 (4.88%)

ATGE

Adtalem Global Education

$55.70

-0.3 (-0.54%)

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

AMAT

Applied Materials

$47.42

-0.07 (-0.15%)

MU

Micron

$47.10

-0.38 (-0.80%)

LRCX

Lam Research

$174.22

1.42 (0.82%)

ZOES

Zoe's Kitchen

$9.52

0.04 (0.42%)

VCEL

Vericel

$11.50

-0.075 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 22

    Aug

  • 04

    Sep

  • 05

    Sep

  • 12

    Sep

  • 27

    Sep

  • 06

    Nov

NVEE

NV5 Global

$84.05

1.55 (1.88%)

18:55
08/16/18
08/16
18:55
08/16/18
18:55
Hot Stocks
NV5 Global CEO sells 190,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

  • 20

    Sep

  • 21

    Sep

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

, GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

18:54
08/16/18
08/16
18:54
08/16/18
18:54
Periodicals
Google submits plans for Moffett Park development, SVBJ reports »

Alphabet's Google…

GOOG

Alphabet

$1,206.00

-7.65 (-0.63%)

GOOGL

Alphabet Class A

$1,223.55

-8.75 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

WMT

Walmart

$98.63

8.39 (9.30%)

18:38
08/16/18
08/16
18:38
08/16/18
18:38
Recommendations
Walmart analyst commentary at Baird »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

AVEO

Aveo Pharmaceuticals

$2.26

0.085 (3.91%)

18:35
08/16/18
08/16
18:35
08/16/18
18:35
Syndicate
Aveo Pharmaceuticals files to sell common stock, no amount given »

Piper Jaffray & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

ZN

Zion Oil & Gas

$2.53

0.16 (6.75%)

18:15
08/16/18
08/16
18:15
08/16/18
18:15
Hot Stocks
Zion Oil & Gas confirms active petroleum system in Megiddo-Jezreel #1 well »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$7.49

0.07 (0.94%)

18:14
08/16/18
08/16
18:14
08/16/18
18:14
Syndicate
Amyris files to sell 7.4M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$12.51

0.01 (0.08%)

18:07
08/16/18
08/16
18:07
08/16/18
18:07
Hot Stocks
Corcept Therapeutics board member Leonard Baker buys $2.2M in common stock »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

ETSY

Etsy

$45.68

0.83 (1.85%)

17:44
08/16/18
08/16
17:44
08/16/18
17:44
Hot Stocks
Etsy chairman Frederick Wilson sells $1M in common stock »

Etsy chairman Frederick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

, TCEHY

Tencent

$0.00

(0.00%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Nvidia says 'Fortnite,' 'PUBG' have strengthened video game market »

Nvidia (NVDA) says gaming…

NVDA

Nvidia

$257.57

-1.41 (-0.54%)

TCEHY

Tencent

$0.00

(0.00%)

DIS

Disney

$112.49

-0.42 (-0.37%)

MSFT

Microsoft

$107.65

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 04

    Sep

  • 12

    Sep

RCUS

Arcus Biosciences

$12.89

-0.05 (-0.39%)

17:37
08/16/18
08/16
17:37
08/16/18
17:37
Hot Stocks
Arcus Biosciences CEO Terry Rosen buys over 28K shares of company stock »

Arcus Biosciences CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

GLD

SPDR Gold Trust

$111.11

-0.1 (-0.09%)

17:30
08/16/18
08/16
17:30
08/16/18
17:30
Hot Stocks
SPDR Gold Trust holdings fall to 773.41MT from 774.59MT »

This is the 4th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSTR

L.B. Foster

$23.05

-0.1 (-0.43%)

17:28
08/16/18
08/16
17:28
08/16/18
17:28
Hot Stocks
Breaking Hot Stocks news story on L.B. Foster »

Legion Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$17.10

-0.1 (-0.58%)

17:25
08/16/18
08/16
17:25
08/16/18
17:25
Hot Stocks
Halozyme director and beneficial owner Randal Kirk sells over 490K shares »

Halozyme director and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.